Dr. Thumar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
140 Hazard Ave
Ste 102
Enfield, CT 06082Phone+1 860-714-9040Fax+1 860-684-8550
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of ConnecticutResidency, Internal Medicine, 2005 - 2008
- B. J. Medical College AhmedabadClass of 2000
Certifications & Licensure
- CT State Medical License 2008 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsPerioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha
JAMA Oncology. 2024-08-01 - 5 citationsA phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.Michael Cecchini, Jeremy S. Kortmansky, Can Cui, Wei Wei, Jaykumar R. Thumar
Cancer. 2020-12-22 - 195 citationsPhase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma...Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip, Sunil R. Hingorani, Jill Lacy
Journal of Clinical Oncology. 2019-02-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: